Application of Virtual Reality in Post-Operative Recovery of a Pediatric Scoliosis Patient Population
Launched by CONNECTICUT CHILDREN'S MEDICAL CENTER · Oct 19, 2023
Trial Information
Current as of August 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how virtual reality (VR) can help young patients recover after surgery for a condition called adolescent idiopathic scoliosis, which is a curvature of the spine that develops during growth. The study aims to see if using VR can reduce pain, lessen the need for pain medication, and help patients move around more easily during physical therapy after their surgery.
To participate, children and teenagers aged 13 to 18 who are having this surgery at Connecticut Children's Hospital may be eligible. However, those with certain conditions, like a history of seizures or specific medical devices, won't be able to join. If chosen, participants can expect to engage with VR as part of their recovery, which may make the recovery process more enjoyable and less painful. This study is currently recruiting participants, so it could be a great opportunity for eligible patients to try something innovative in their post-operative care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All pediatric patients (ages 13-18) at Connecticut Children's undergoing surgical correction for idiopathic scoliosis over a span of 12 months
- Exclusion Criteria:
- • History of seizures
- • Cognitive developmental delay precluding participation in VR
- • Head or neck surgery that does not allow a head-mounted display to be worn safely
- • Chronic pain requiring the daily use of opioids for more than 2 weeks prior to the procedure
- • Non-English speakers
- • Side effects during screening
- • Patients with vagal nerve stimulators, cardiac pacemakers, and/or cochlear implants that may receive interference from the VR device
About Connecticut Children's Medical Center
Connecticut Children's Medical Center is a leading pediatric healthcare institution dedicated to improving the health and well-being of children through innovative research and clinical care. As a recognized sponsor of clinical trials, the center is committed to advancing pediatric medicine by conducting rigorous studies that address critical health issues affecting children. With a focus on collaboration among multidisciplinary teams of healthcare professionals and researchers, Connecticut Children's Medical Center aims to translate scientific discoveries into effective treatments, ensuring that the latest advances in medicine are accessible to young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hartford, Connecticut, United States
Patients applied
Trial Officials
David Hersh, MD
Principal Investigator
Connecticut Children's Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported